These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 30741437)

  • 1. Health benefits of resveratrol: Evidence from clinical studies.
    Singh AP; Singh R; Verma SS; Rai V; Kaschula CH; Maiti P; Gupta SC
    Med Res Rev; 2019 Sep; 39(5):1851-1891. PubMed ID: 30741437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials.
    Tripathi AK; Ray AK; Mishra SK
    Beni Suef Univ J Basic Appl Sci; 2022; 11(1):16. PubMed ID: 35127957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.
    Pannu N; Bhatnagar A
    Biomed Pharmacother; 2019 Jan; 109():2237-2251. PubMed ID: 30551481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Resveratrol Administration in Human Obesity.
    Mongioì LM; La Vignera S; Cannarella R; Cimino L; Compagnone M; Condorelli RA; Calogero AE
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33921991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial.
    Abdollahi S; Salehi-Abargouei A; Tabatabaie M; Sheikhha MH; Fallahzadeh H; Rahmanian M; Toupchian O; Karimi-Nazari E; Mozaffari-Khosravi H
    BMJ Open; 2019 Jul; 9(7):e026337. PubMed ID: 31278094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound.
    Samuel VP; Gupta G; Dahiya R; Jain DA; Mishra A; Dua K
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):529-537. PubMed ID: 32422008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Basis of the Beneficial Actions of Resveratrol.
    Repossi G; Das UN; Eynard AR
    Arch Med Res; 2020 Feb; 51(2):105-114. PubMed ID: 32111491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol?
    Tain YL; Hsu CN
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer.
    Kulashekar M; Stom SM; Peuler JD
    J Am Osteopath Assoc; 2018 Sep; 118(9):596-605. PubMed ID: 30178049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial action of resveratrol: How and why?
    Diaz-Gerevini GT; Repossi G; Dain A; Tarres MC; Das UN; Eynard AR
    Nutrition; 2016 Feb; 32(2):174-8. PubMed ID: 26706021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder.
    Barone R; Rizzo R; Tabbì G; Malaguarnera M; Frye RE; Bastin J
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome.
    Pérez-Torres I; Ruiz-Ramírez A; Baños G; El-Hafidi M
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):25-37. PubMed ID: 22721439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of resveratrol: addressing the controversies.
    Bitterman JL; Chung JH
    Cell Mol Life Sci; 2015 Apr; 72(8):1473-88. PubMed ID: 25548801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Resveratrol in the Treatment of Metabolic Syndrome.
    Hou CY; Tain YL; Yu HR; Huang LT
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30695995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol in cholesterol metabolism and atherosclerosis.
    Voloshyna I; Hussaini SM; Reiss AB
    J Med Food; 2012 Sep; 15(9):763-73. PubMed ID: 22856383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of resveratrol in diabetes: rationale, strategies and challenges.
    Bagul PK; Banerjee SK
    Curr Mol Med; 2015; 15(4):312-30. PubMed ID: 25941821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer.
    Rossi EL; Khatib SA; Doerstling SS; Bowers LW; Pruski M; Ford NA; Glickman RD; Niu M; Yang P; Cui Z; DiGiovanni J; Hursting SD
    Mol Carcinog; 2018 Mar; 57(3):393-407. PubMed ID: 29197120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?
    Timmers S; Hesselink MK; Schrauwen P
    Ann N Y Acad Sci; 2013 Jul; 1290():83-9. PubMed ID: 23855469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol targeting the Wnt signaling pathway: A focus on therapeutic activities.
    Ashrafizadeh M; Ahmadi Z; Farkhondeh T; Samarghandian S
    J Cell Physiol; 2020 May; 235(5):4135-4145. PubMed ID: 31637721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.